UNSPSC 51162310: Acetaminophen/chlorpheniramine/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162310 Acetaminophen/chlorpheniramine/phenylephrine is a Commodity code that in practice captures state and local procurement of pharmaceutical products and medical supplies for correctional healthcare, public health initiatives, and emergency response programs. The recent opportunities under this code reflect broader acquisition patterns for prescription and over-the-counter medications, parenteral solutions, and opioid-reversal agents distributed through state health and corrections agencies to support incarcerated populations and community health programs. State and local buyers include state departments of corrections and county health departments, with solicitations structured as competitive RFQ and IFB processes that emphasize fixed pricing, delivery speed, and vendor qualification through insurance, clearance, and compliance verification.

The code shows recent activity in Washington and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with an October 7, 2026 response deadline, seeking parenteral products, services, and equipment including total parenteral nutrition (TPN), peripheral parenteral nutrition (PPN), and intravenous solutions for eight correctional facilities across three regions; the agency anticipates awarding up to three contractors per region and may select multiple vendors, with the initial contract running November 26, 2026 through June 30, 2030. The procurement includes set-aside goals for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with a subcontractor inclusion plan requirement. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period.